PFBT
RYTM icon

Parkside Financial Bank & Trust’s Rhythm Pharmaceuticals RYTM Stock Holding History

Parkside Financial Bank & Trust’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.87K Hold
33
– – ﹤0.01% 1996
2025
Q4 		$3.53K Hold
33
– – ﹤0.01% 1905
2025
Q3 		$3.33K Hold
33
– – ﹤0.01% 1851
2025
Q2 		$2.09K Buy
33
+13
+65% +$796 ﹤0.01% 1989
2025
Q1 		$1.06K Buy
+20
New +$1.11K ﹤0.01% 2085

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Parkside Financial Bank & Trust's RYTM Position: Q1 2026 in Review

Parkside Financial Bank & Trust held its Rhythm Pharmaceuticals (RYTM) position steady in Q1 2026 at 33 shares worth $2.87K. The position accounts for ﹤0.01% of the portfolio, ranked #1996.

Parkside Financial Bank & Trust first reported a position in RYTM in Q1 2025 and has held it in 5 quarters since. The position peaked at $3.53K in Q4 2025. 285 funds tracked by Wall St. Rank hold RYTM as of Q1 2026.

  • Parkside Financial Bank & Trust held 33 shares of Rhythm Pharmaceuticals worth $2.87K as of Q1 2026.
  • Parkside Financial Bank & Trust left its Rhythm Pharmaceuticals share count unchanged in Q1 2026.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #1996 holding.
  • Parkside Financial Bank & Trust first reported a position in Rhythm Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • Parkside Financial Bank & Trust's Rhythm Pharmaceuticals position peaked at $3.53K in Q4 2025.
  • 285 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.